|
| 36383758 | National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. | J Urol | 2023 |
| 37608258 | Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4Â weeks versus 2Â weeks (SHORTER). | BMC Cancer | 2023 |
| 37353441 | A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer. | Eur Urol | 2023 |
| 37015291 | Study protocol for a prospective, multi-centered randomized controlled trial comparing pelvic fascia-sparing radical prostatectomy with conventional robotic-assisted prostatectomy: The PARTIAL trial. | Contemp Clin Trials | 2023 |
| 37236832 | Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis. | Eur Urol Oncol | 2023 |
| 34023914 | Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer. | Cancer Immunol Immunother | 2022 |
| 35347517 | Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. | Ann Surg Oncol | 2022 |
| 35490048 | A multidisciplinary approach to optimize primary prostate cancer biobanking. | Urol Oncol | 2022 |
| 34985786 | Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer. | Prostate | 2022 |
| 34985341 | Reply by Authors. | J Urol | 2022 |
| 35039232 | Sociodemographic Disparities in Access to Chemotherapy for Bladder Cancer. | Clin Genitourin Cancer | 2022 |
| 35034804 | Novel nomograms to predict muscle invasion and lymph node metastasis in upper tract urothelial carcinoma. | Urol Oncol | 2022 |
| 34993496 | Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. | HGG Adv | 2022 |
| 35050902 | Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci. | JCI Insight | 2022 |
| 35230440 | Use of Intravesical Chemotherapy in the US Following Publication of a Randomized Clinical Trial. | JAMA Netw Open | 2022 |
| 34587660 | Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. | Mol Carcinog | 2022 |
| 34433303 | Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial. | J Urol | 2022 |
| 34380053 | Prostate Cancer Screening for Gay Men in the United States. | Urology | 2022 |
| 34629282 | Does neoadjuvant chemotherapy diminish the sex disparity in bladder cancer survival after radical cystectomy? | Urol Oncol | 2022 |
| 34454852 | The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. | Eur Urol Focus | 2022 |
| 34711530 | Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States. | Eur Urol Focus | 2022 |
| 32385798 | Patient injuries and malfunctions associated with robotic prostatectomy: review of the manufacturer and user facility device experience database. | J Robot Surg | 2021 |
| 33793062 | Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert<sup>®</sup> Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer. | BJU Int | 2021 |
| 33766715 | The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma. | Urology | 2021 |
| 33677615 | Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma. | Cancer Chemother Pharmacol | 2021 |
| 34379101 | Response to a Randomized Trial on Mannitol Use During Partial Nephrectomy. | JAMA Surg | 2021 |
| 34181469 | Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy. | J Urol | 2021 |
| 34181470 | Tobacco Screening and Treatment during Outpatient Urology Office Visits in the United States. Letter.<i>J Urol</i> 2021; <b>205:</b> 1755. | J Urol | 2021 |
| 33934964 | Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer. | Urol Oncol | 2021 |
| 34358591 | Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2. | Urology | 2021 |
| 34026658 | Changes in Urologic Operative Practice at the Beginning of the COVID-19 Pandemic in a Large, National Cohort. | Front Oncol | 2021 |
| 33127299 | The role of surgical experience in patient selection, surgical quality, and outcomes in robot-assisted radical cystectomy. | Urol Oncol | 2021 |
| 31301468 | Novel Incision-free Device for Transvaginal Apical Pelvic Organ Prolapse Repair. | J Minim Invasive Gynecol | 2020 |
| 31948677 | Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States. | Urology | 2020 |
| 33372693 | Reply to The risk factors of upgrading in prostate cancer. | Cancer | 2020 |
| 33272422 | AUTHOR REPLY. | Urology | 2020 |
| 33272421 | AUTHOR REPLY. | Urology | 2020 |
| 32631491 | Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. | Lancet Oncol | 2020 |
| 32896584 | Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis. | Urology | 2020 |
| 32979705 | Contemporary Results and Clinical Utility of Renal Mass Biopsies in the Setting of Ablative Therapy: A single center experience. | Cancer Treat Res Commun | 2020 |
| 32306494 | A comparative propensity score-matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. | BJU Int | 2020 |
| 32320063 | Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance. | Cancer | 2020 |
| 30470630 | Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries? | Clin Genitourin Cancer | 2019 |
| 37300112 | Reply by Authors. | Urol Pract | 2019 |
| 37300105 | Ambulatory Bladder Cancer Care in the United States. | Urol Pract | 2019 |
| 31815952 | Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series. | PLoS One | 2019 |
| 29914269 | Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses. | J Endourol | 2019 |
| 31469605 | Reply by Authors. | J Urol | 2019 |
| 31290707 | Association of Smoking and Death from Genitourinary Malignancies: Analysis of the National Longitudinal Mortality Study. | J Urol | 2019 |
| 31201825 | Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer. | Urology | 2019 |